IamFluidics Secures Funding to Accelerate Micro-Encapsulation Technology
Enschede, Thursday, 31 October 2024.
IamFluidics, an Enschede-based spin-off from the University of Twente, has secured funding from Oost NL and Innovation Industries to accelerate the market introduction of its patented high-speed micro-encapsulation technology. This breakthrough has applications in pharmaceuticals, cosmetics, and food industries, enabling the creation of microscopic capsules for targeted drug delivery and sustainable alternatives to microplastics in cosmetics.
Revolutionizing Industries with Micro-Encapsulation
IamFluidics, headquartered in Enschede, The Netherlands, is at the forefront of innovation with its micro-encapsulation technology. This technology is pivotal in several industries, including pharmaceuticals, cosmetics, and food. By encapsulating ingredients at high speeds, IamFluidics addresses critical challenges such as targeted drug delivery and sustainable cosmetics solutions. Their method allows for the creation of capsules smaller than human hair for pharmaceuticals and larger, pearl-sized capsules for cosmetics[1].
The Mechanism Behind the Innovation
The core of IamFluidics’ technology lies in its ability to produce tiny droplets encapsulated by a protective layer. These droplets release active substances precisely when needed, a feature particularly beneficial for drug delivery systems. This process not only enhances the efficacy of pharmaceuticals but also provides a sustainable alternative to microplastics commonly used in the cosmetics industry. The protective layers can be crafted from sustainable materials, making the technology environmentally friendly[1].
Strategic Funding and Future Prospects
The recent funding from Oost NL and Innovation Industries is a significant milestone for IamFluidics. It enables the company to advance its commercialization strategy, focusing on medical applications, while also expanding its reach in the food and cosmetics sectors. According to Leonard van Bokhorst, CEO of IamFluidics, this investment will expedite the transition from development to market-ready solutions, thereby amplifying their impact across various fields[1].
Broader Applications and Societal Impact
IamFluidics’ platform technology extends beyond pharmaceuticals and cosmetics. It holds promise in the food industry, particularly in the encapsulation of sensitive vitamins, fats, and probiotics. This versatility underlines its potential to address broad societal challenges, including those related to health and sustainability. The technology’s ability to encapsulate living cells for cell therapy further showcases its potential impact across diverse sectors[1].